{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:39:20Z","timestamp":1769816360610,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insulin-like growth factor (IGF)-I binds to the ECM protein vitronectin (VN) through IGF binding proteins (IGFBPs) to enhance proliferation and migration of skin keratinocytes and fibroblasts. Although evidence exists for the role of individual components of the complex (IGF-I, IGFBP-3 and VN), the cellular functions stimulated by these proteins together as a complex remains un-investigated in melanoma cells. We report here that the IGF-I:IGFBP-3:VN trimeric complex stimulates a dose-dependent increase in the proliferation and migration of WM35 and Sk-MEL28 melanoma cells. In 3D Matrigel<jats:sup>\u2122<\/jats:sup>and hydrogel cultures, both cell lines formed primary tumor-like spheroids, which increased in size in a dose-dependent manner in response to the trimeric complex. Furthermore, we reveal IGFBP-3:VN protein complexes in malignant melanoma and squamous cell carcinoma patient tissues, where the IGFBP-3:VN complex was seen to be predominantly tumor cell-associated. Peptide antagonists designed to target the binding of IGF-I:IGFBP-3 to VN were demonstrated to inhibit IGF-I:IGFBP-3:VN-stimulated cell migration, invasion and 3D tumor cell growth of melanoma cells. Overall, this study provides new data on IGF:ECM interactions in skin malignancies and demonstrates the potential usefulness of a growth factor:ECM-disrupting strategy for abrogating tumor progression.<\/jats:p>","DOI":"10.1038\/s41598-017-19073-4","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T10:39:31Z","timestamp":1515407971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression"],"prefix":"10.1038","volume":"8","author":[{"given":"Berline","family":"Murekatete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Shokoohmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-6745","authenticated-orcid":false,"given":"Jacqui","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipsa","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Meinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett G.","family":"Hollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zee","family":"Upton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"19073_CR1","first-page":"572","volume":"7","author":"A Sandru","year":"2014","unstructured":"Sandru, A., Voinea, S., Panaitescu, E. & Blidaru, A. Survival rates of patients with metastatic malignant melanoma. Journal of medicine and life 7, 572 (2014).","journal-title":"Journal of medicine and life"},{"key":"19073_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1006\/cyto.1999.0614","volume":"12","author":"E L\u00e1z\u00e1r-Moln\u00e1r","year":"2000","unstructured":"L\u00e1z\u00e1r-Moln\u00e1r, E., Hegyesi, H., T\u00f3th, S. & Falus, A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12, 547\u2013554 (2000).","journal-title":"Cytokine"},{"key":"19073_CR3","first-page":"87","volume":"13","author":"K Satyamoorthy","year":"2002","unstructured":"Satyamoorthy, K., Li, G., Vaidya, B., Kalabis, J. & Herlyn, M. Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell growth and differentiation 13, 87\u201393 (2002).","journal-title":"Cell growth and differentiation"},{"key":"19073_CR4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/jid.2008.124","volume":"128","author":"JT Lee","year":"2008","unstructured":"Lee, J. T., Brafford, P. & Herlyn, M. Unraveling the mysteries of IGF-1 signaling in melanoma. Journal of Investigative Dermatology 128, 1358\u20131360 (2008).","journal-title":"Journal of Investigative Dermatology"},{"key":"19073_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/08977190009001068","volume":"17","author":"L Kanter-Lewensohn","year":"2000","unstructured":"Kanter-Lewensohn, L., Dricu, A., Girnita, L., Wejde, J. & Larsson, O. Expression of Insulin-Like Growth Factor-1 Receptor (IGF-1R) and p27Kip1 in Melanocyte Tumors: A Potential Regulatory Role of IGF-1 Pathway in Distribution of p27Kip1 between Different Cyclins. Growth Factors 17, 193\u2013202 (2000).","journal-title":"Growth Factors"},{"key":"19073_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1530\/JOE-10-0377","volume":"209","author":"S-H Kim","year":"2011","unstructured":"Kim, S.-H., Turnbull, J. & Guimond, S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. Journal of Endocrinology 209, 139\u2013151 (2011).","journal-title":"Journal of Endocrinology"},{"key":"19073_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1096\/fasebj.11.1.9034166","volume":"11","author":"J Taipale","year":"1997","unstructured":"Taipale, J. & Keski-Oja, J. Growth factors in the extracellular matrix. The FASEB Journal 11, 51\u201359 (1997).","journal-title":"The FASEB Journal"},{"key":"19073_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc2714","volume":"9","author":"MB Meads","year":"2009","unstructured":"Meads, M. B., Gatenby, R. A. & Dalton, W. S. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nature Reviews Cancer 9, 665\u2013674 (2009).","journal-title":"Nature Reviews Cancer"},{"key":"19073_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcp.22183","volume":"224","author":"J Beattie","year":"2010","unstructured":"Beattie, J., McIntosh, L. & Van der Walle, C. F. Cross\u2010talk between the insulin\u2010like growth factor (IGF) axis and membrane integrins to regulate cell physiology. Journal of cellular physiology 224, 605\u2013611 (2010).","journal-title":"Journal of cellular physiology"},{"key":"19073_CR10","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1210\/en.2002-221102","volume":"144","author":"DR Clemmons","year":"2003","unstructured":"Clemmons, D. R. & Maile, L. A. Minireview: Integral Membrane Proteins that Function Coordinately with the Insulin-Like Growth Factor I Receptor to Regulate Intracellular Signaling. Endocrinology 144, 1664\u20131670, https:\/\/doi.org\/10.1210\/en.2002-221102 (2003).","journal-title":"Endocrinology"},{"key":"19073_CR11","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/en.2002-221086","volume":"144","author":"JA Kricker","year":"2003","unstructured":"Kricker, J. A., Towne, C. L., Firth, S. M., Herington, A. C. & Upton, Z. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144, 2807\u20132815 (2003).","journal-title":"Endocrinology"},{"key":"19073_CR12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/1535-7163.MCT-15-0907","volume":"15","author":"AS Kashyap","year":"2016","unstructured":"Kashyap, A. S. et al. Antagonists of IGF: vitronectin interactions inhibit IGF-I\u2013induced breast cancer cell functions. Molecular cancer therapeutics 15, 1602\u20131613 (2016).","journal-title":"Molecular cancer therapeutics"},{"key":"19073_CR13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/iub.1203","volume":"65","author":"DI Leavesley","year":"2013","unstructured":"Leavesley, D. I. et al. Vitronectin\u2014Master controller or micromanager? IUBMB life 65, 807\u2013818 (2013).","journal-title":"IUBMB life"},{"key":"19073_CR14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.0022-202X.2004.22527.x","volume":"122","author":"C Hyde","year":"2004","unstructured":"Hyde, C., Hollier, B., Anderson, A., Harkin, D. & Upton, Z. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. Journal of Investigative Dermatology 122, 1198\u20131206 (2004).","journal-title":"Journal of Investigative Dermatology"},{"key":"19073_CR15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1210\/en.2010-0897","volume":"152","author":"AS Kashyap","year":"2011","unstructured":"Kashyap, A. S. et al. Insulin-like growth factor-I: vitronectin complex-induced changes in gene expression effect breast cell survival and migration. Endocrinology 152, 1388\u20131401 (2011).","journal-title":"Endocrinology"},{"key":"19073_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1210\/en.2007-0740","volume":"149","author":"BG Hollier","year":"2008","unstructured":"Hollier, B. G., Kricker, J. A., Van Lonkhuyzen, D. R., Leavesley, D. I. & Upton, Z. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-kinase\/AKT pathway by \u03b1v-integrins and the IGF-I receptor. Endocrinology 149, 1075\u20131090 (2008).","journal-title":"Endocrinology"},{"key":"19073_CR17","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1074\/jbc.271.6.3247","volume":"271","author":"S Aznavoorian","year":"1996","unstructured":"Aznavoorian, S., Stracke, M. L., Parsons, J., McClanahan, J. & Liotta, L. A. Integrin Mediates Chemotactic and Haptotactic Motility in Human Melanoma Cells through Different Signaling Pathways. Journal of Biological Chemistry 271, 3247\u20133254 (1996).","journal-title":"Journal of Biological Chemistry"},{"key":"19073_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<116::AID-IJC19>3.0.CO;2-G","volume":"71","author":"A Stahl","year":"1997","unstructured":"Stahl, A. & Mueller, B. M. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system. International journal of cancer 71, 116\u2013122 (1997).","journal-title":"International journal of cancer"},{"key":"19073_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-005-1572-1","volume":"24","author":"S Kuphal","year":"2005","unstructured":"Kuphal, S., Bauer, R. & Bosserhoff, A.-K. Integrin signaling in malignant melanoma. Cancer and Metastasis Reviews 24, 195\u2013222 (2005).","journal-title":"Cancer and Metastasis Reviews"},{"key":"19073_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian, S. L., Taube, J. M., Anders, R. A. & Pardoll, D. M. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nature reviews. Cancer 16, 275\u2013287, https:\/\/doi.org\/10.1038\/nrc.2016.36 (2016).","journal-title":"Nature reviews. Cancer"},{"key":"19073_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-016-0174-8","volume":"17","author":"KS Smalley","year":"2016","unstructured":"Smalley, K. S., Eroglu, Z. & Sondak, V. K. Combination Therapies for Melanoma: A New Standard of Care? American journal of clinical dermatology 17, 99\u2013105, https:\/\/doi.org\/10.1007\/s40257-016-0174-8 (2016).","journal-title":"American journal of clinical dermatology"},{"key":"19073_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nprot.2016.037","volume":"11","author":"D Loessner","year":"2016","unstructured":"Loessner, D. et al. Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms. Nature protocols 11, 727\u2013746 (2016).","journal-title":"Nature protocols"},{"key":"19073_CR23","unstructured":"Beaumont, K. A., Mohana-Kumaran, N. & Haass, N. K. In Healthcare. 27\u201346 (Multidisciplinary Digital Publishing Institute)."},{"key":"19073_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker, A. I. et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Medical Genomics 1, 13\u201313, https:\/\/doi.org\/10.1186\/1755-8794-1-13 (2008).","journal-title":"BMC Medical Genomics"},{"key":"19073_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/0008-5472.CAN-10-0605","volume":"71","author":"C Laurent","year":"2011","unstructured":"Laurent, C. et al. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res 71, 666\u2013674, https:\/\/doi.org\/10.1158\/0008-5472.can-10-0605 (2011).","journal-title":"Cancer Res"},{"key":"19073_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1524-475X.2009.00466.x","volume":"17","author":"GS Schultz","year":"2009","unstructured":"Schultz, G. S. & Wysocki, A. Interactions between extracellular matrix and growth factors in wound healing. Wound repair and regeneration 17, 153\u2013162 (2009).","journal-title":"Wound repair and regeneration"},{"key":"19073_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ceb.2012.07.001","volume":"24","author":"MF Brizzi","year":"2012","unstructured":"Brizzi, M. F., Tarone, G. & Defilippi, P. Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Current opinion in cell biology 24, 645\u2013651 (2012).","journal-title":"Current opinion in cell biology"},{"key":"19073_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196, 395\u2013406 (2012).","journal-title":"J Cell Biol"},{"key":"19073_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.yexcr.2005.01.004","volume":"305","author":"B Hollier","year":"2005","unstructured":"Hollier, B., Harkin, D. G., Leavesley, D. & Upton, Z. Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes. Experimental cell research 305, 221\u2013232 (2005).","journal-title":"Experimental cell research"},{"key":"19073_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcp.22183","volume":"224","author":"J Beattie","year":"2010","unstructured":"Beattie, J., McIntosh, L. & van der Walle, C. F. Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol 224, 605\u2013611, https:\/\/doi.org\/10.1002\/jcp.22183 (2010).","journal-title":"J Cell Physiol"},{"key":"19073_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2010.09.001","volume":"57","author":"A Klein","year":"2011","unstructured":"Klein, A., Capitanio, J. S., Maria, D. A. & Ruiz, I. R. G. Gene expression in SK-Mel-28 human melanoma cells treated with the snake venom jararhagin. Toxicon 57, 1\u20138 (2011).","journal-title":"Toxicon"},{"key":"19073_CR32","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1158\/1535-7163.MCT-06-0424","volume":"5","author":"Y Xi","year":"2006","unstructured":"Xi, Y. et al. Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Molecular cancer therapeutics 5, 3078\u20133084 (2006).","journal-title":"Molecular cancer therapeutics"},{"key":"19073_CR33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.30202","volume":"139","author":"I Ortega\u2010Mart\u00ednez","year":"2016","unstructured":"Ortega\u2010Mart\u00ednez, I. et al. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I\u2013II early\u2010stage melanoma. International journal of cancer 139, 1598\u20131607 (2016).","journal-title":"International journal of cancer"},{"key":"19073_CR34","first-page":"7318","volume":"61","author":"K Satyamoorthy","year":"2001","unstructured":"Satyamoorthy, K., Li, G., Vaidya, B., Patel, D. & Herlyn, M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and \u03b2-catenin pathways. Cancer research 61, 7318\u20137324 (2001).","journal-title":"Cancer research"},{"key":"19073_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ghir.2007.01.004","volume":"17","author":"DR Clemmons","year":"2007","unstructured":"Clemmons, D. R., Maile, L. A., Ling, Y., Yarber, J. & Busby, W. H. Role of the integrin \u03b1V\u03b23 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress. Growth Hormone & IGF Research 17, 265\u2013270, https:\/\/doi.org\/10.1016\/j.ghir.2007.01.004 (2007).","journal-title":"Growth Hormone & IGF Research"},{"key":"19073_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nature methods 4, 359\u2013365 (2007).","journal-title":"Nature methods"},{"key":"19073_CR37","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes, R. O. The extracellular matrix: not just pretty fibrils. Science 326, 1216\u20131219 (2009).","journal-title":"Science"},{"key":"19073_CR38","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz, C., Stewart, K. M. & Weaver, V. M. The extracellular matrix at a glance. J Cell Sci 123, 4195\u20134200 (2010).","journal-title":"J Cell Sci"},{"key":"19073_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ijc.24727","volume":"126","author":"GF \u00d8y","year":"2010","unstructured":"\u00d8y, G. F. et al. Biological effects induced by insulin\u2010like growth factor binding protein 3 (IGFBP\u20103) in malignant melanoma. International journal of cancer 126, 350\u2013361 (2010).","journal-title":"International journal of cancer"},{"key":"19073_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","volume":"18","author":"MA Davies","year":"2012","unstructured":"Davies, M. A. The role of the PI3K-AKT pathway in melanoma. The Cancer Journal 18, 142\u2013147 (2012).","journal-title":"The Cancer Journal"},{"key":"19073_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian, B. C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annual Review of Pathology: Mechanisms of Disease 9, 239\u2013271 (2014).","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"19073_CR42","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/j.1365-2133.2007.07821.x","volume":"156","author":"F Meier","year":"2007","unstructured":"Meier, F. et al. Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. British Journal of Dermatology 156, 1204\u20131213 (2007).","journal-title":"British Journal of Dermatology"},{"key":"19073_CR43","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/CMR.0000000000000107","volume":"24","author":"F Tas","year":"2014","unstructured":"Tas, F., Karabulut, S., Bilgin, E., Tastekin, D. & Duranyildiz, D. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. Melanoma research 24, 475\u2013479 (2014).","journal-title":"Melanoma research"},{"key":"19073_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.18388\/abp.2010_2372","volume":"57","author":"ME Janik","year":"2010","unstructured":"Janik, M. E., Przybylo, M., Pochec, E., Pokrywka, M. & Litynska, A. Effect of \u03b13\u03b21 and \u03b1v\u03b23 integrin glycosylation on interaction of melanoma cells with vitronectin. Acta Biochimica Polonica 57, 55 (2010).","journal-title":"Acta Biochimica Polonica"},{"key":"19073_CR45","unstructured":"Mesnard, L. et al. In Journal of Investigative Dermatology. S140\u2013S140."},{"key":"19073_CR46","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10637-012-9811-0","volume":"30","author":"A Gombos","year":"2012","unstructured":"Gombos, A., Metzger-Filho, O., Dal Lago, L. & Awada-Hussein, A. Clinical development of insulin-like growth factor receptor\u20141 (IGF-1R) inhibitors: At the crossroad? Investigational new drugs 30, 2433\u20132442 (2012).","journal-title":"Investigational new drugs"},{"key":"19073_CR47","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2010.34.0000","volume":"29","author":"AS Pappo","year":"2011","unstructured":"Pappo, A. S. et al. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. Journal of Clinical Oncology 29, 4541\u20134547 (2011).","journal-title":"Journal of Clinical Oncology"},{"key":"19073_CR48","doi-asserted-by":"crossref","unstructured":"Macaulay, V. et al. Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors. Annals of oncology, mds511 (2012).","DOI":"10.1093\/annonc\/mds511"},{"key":"19073_CR49","unstructured":"Smalley, K. S. & McArthur, G. A. In Seminars in oncology. 204\u2013214 (Elsevier)."},{"key":"19073_CR50","doi-asserted-by":"crossref","unstructured":"Cao, J. et al. Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy. Oncotarget 5 (2016).","DOI":"10.18632\/oncotarget.10770"},{"key":"19073_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/0008-5472.CAN-14-3358","volume":"76","author":"B Herkert","year":"2016","unstructured":"Herkert, B. et al. Maximizing the efficacy of MAPK-targeted treatment in PTENLOF\/BRAFMUT melanoma through PI3K and IGF1R inhibition. Cancer research 76, 390\u2013402 (2016).","journal-title":"Cancer research"},{"key":"19073_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/2159-8290.CD-13-0961","volume":"4","author":"DB Solit","year":"2014","unstructured":"Solit, D. B. & Rosen, N. Towards a unified model of RAF inhibitor resistance. Cancer discovery 4, 27\u201330 (2014).","journal-title":"Cancer discovery"},{"key":"19073_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/jmcb\/mjs021","volume":"4","author":"J-K Won","year":"2012","unstructured":"Won, J.-K. et al. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. Journal of molecular cell biology 4, 153\u2013163 (2012).","journal-title":"Journal of molecular cell biology"},{"key":"19073_CR54","unstructured":"Weigelt, B. & Bissell, M. J. In Seminars in cancer biology. 311\u2013321 (Elsevier)."},{"key":"19073_CR55","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O S\u00f6derberg","year":"2006","unstructured":"S\u00f6derberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nature methods 3, 995\u20131000 (2006).","journal-title":"Nature methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-19073-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-19073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-19073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:12:20Z","timestamp":1719742340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-19073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19073"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-19073-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Queensland University of Technology has filed a patent related to the peptides outlined in this study (Patent# WO 2014078896 A1) and this has been acquired by Factor Therapeutics Ltd. A.S.K., Z.U. and B.G.H. are named inventors on this patent. Z.U. has purchased stock in Factor Therapeutics. The other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"583"}}